Duane A. Mitchell

13.1k citations

181 papers · 9.0k indexed · 4 hit papers · h-index 48

Impact in

Genetics top 0.1%
- Glioma Diagnosis and Treatment
Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction

Papers in ⓘ

Immunology 117
- Immunotherapy and Immune Responses 95
- Immune Cell Function and Interaction 22
- Immune cells in cancer 16
Genetics 47
- Glioma Diagnosis and Treatment 46

Co-authors: John H. Sampson (55 shared papers)Darell D. Bigner (32 shared papers)Gary E. Archer (29 shared papers)Elias Sayour (58 shared papers)James E. Herndon (20 shared papers)Smita K. Nair (14 shared papers)Allan H. Friedman (10 shared papers)Roger E. McLendon (12 shared papers)
Journals: Neuro-Oncology (42 papers)Journal of Clinical Oncology (13 papers)Clinical Cancer Research (11 papers)OncoImmunology (8 papers)Journal of Neuro-Oncology (7 papers)
Partner nations: United States China Germany

In The Last Decade

Duane A. Mitchell

172 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

Cancer mRNA vaccines: clinical advances and future opportunities 2024 · 94 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Reviews Clinical Oncology
2022 npj Digital Medicine
2015 Nature
2010 Journal of Clinical Oncology

Peers

Countries citing papers authored by Duane A. Mitchell

Since Specialization

Citations

This map shows the geographic impact of Duane A. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duane A. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duane A. Mitchell more than expected).

Fields of papers citing papers by Duane A. Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duane A. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duane A. Mitchell. The network helps show where Duane A. Mitchell may publish in the future.

Co-authors

The 25 scholars most cited alongside Duane A. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Duane A. Mitchell Line = papers co-authored together Duane A. Mitchell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma Journal of Clinical Oncology ·John H. Sampson, Amy B. Heimberger, Gary E. Archer, Kenneth Aldape, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner Hit paper breakdown →	2010	613
2	Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma Cancer Research ·Peter E. Fecci, Duane A. Mitchell, John F. Whitesides, Weihua Xie, Allan H. Friedman, Gary E. Archer, James E. Herndon, Darell D. Bigner, Glenn Dranoff, John H. Sampson	2006	468
3	A large language model for electronic health records npj Digital Medicine ·Xi Yang, Aokun Chen, Nima PourNejatian, Hoo Chang Shin, Kaleb E Smith, Christopher Parisien, Colin B. Compas, Cheryl Martin, Anthony Costa, Mona G. Flores, Ying Zhang, Tanja Magoč, Christopher A. Harle, Gloria Lipori, Duane A. Mitchell, William R. Hogan, Elizabeth Shenkman, Jiang Bian, Yonghui Wu Hit paper breakdown →	2022	434
4	Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients Nature ·Duane A. Mitchell, Kristen A. Batich, Michael D. Gunn, Min-Nung Huang, Luis Sánchez-Pérez, Smita K. Nair, Kendra L. Congdon, Elizabeth A. Reap, Gary E. Archer, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, James E. Herndon, April Coan, Roger E. McLendon, David A. Reardon, James J. Vredenburgh, Darell D. Bigner, John H. Sampson Hit paper breakdown →	2015	410
5	Proteomic and immunologic analyses of brain tumor exosomes The FASEB Journal ·Michael W. Graner, Óscar Álzate, Angelika M. Dechkovskaia, Jack D. Keene, John H. Sampson, Duane A. Mitchell, Darell D. Bigner	2008	342
6	CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors Nature Communications ·Linchun Jin, Haipeng Tao, Aida Karachi, Yu Long, Alicia Y. Hou, Na Meng, Kyle Dyson, Adam Grippin, Loic P. Deleyrolle, Wang Zhang, Didier A. Rajon, Qiong J. Wang, James C. Yang, Jesse Kresak, Elias Sayour, Maryam Rahman, Frank J. Bova, Zhiguo Lin, Duane A. Mitchell, Jianping Huang	2019	285
7	Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma Neuro-Oncology ·John H. Sampson, Kenneth Aldape, Gerald E. Archer, April Coan, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner, Amy B. Heimberger	2010	279
8	Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function Clinical Cancer Research ·Peter E. Fecci, Hidenobu Ochiai, Duane A. Mitchell, Peter M. Grossi, Alison E. Sweeney, Gary E. Archer, Thomas J. Cummings, James P. Allison, Darell D. Bigner, John H. Sampson	2007	265
9	CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas Proceedings of the National Academy of Sciences ·Joseph Flores‐Toro, Defang Luo, Adithya Gopinath, Matthew R. Sarkisian, James J. Campbell, Israel Charo, Rajinder Singh, Thomas J. Schall, Meenal Datta, Rakesh K. Jain, Duane A. Mitchell, Jeffrey K. Harrison	2019	244
10	Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination Clinical Cancer Research ·Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis Sánchez-Pérez, Smita K. Nair, Robert J. Schmittling, Pam Norberg, Weihua Xie, James E. Herndon, Patrick Healy, Roger E. McLendon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, Gordana Vlahovic, Duane A. Mitchell, John H. Sampson	2017	242
11	An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme Molecular Cancer Therapeutics ·John H. Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, James E. Herndon, Denise Lally-Goss, Sharon McGehee-Norman, Alison Paolino, David A. Reardon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner	2009	221
12	Temozolomide for immunomodulation in the treatment of glioblastoma Neuro-Oncology ·Aida Karachi, Farhad Dastmalchi, Duane A. Mitchell, Maryam Rahman	2018	208
13	Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity Nature Communications ·Christina A. von Roemeling, Yifan Wang, Yaqing Qie, Hengfeng Yuan, Zhao Hai, Xiujie Liu, Zhaogang Yang, Mingming Yang, Weiye Deng, Katelyn A. Bruno, Charles K. F. Chan, Andrew S. Lee, Stephen S. Rosenfeld, Kyuson Yun, Aaron J. Johnson, Duane A. Mitchell, Wen Jiang, Betty Y.S. Kim	2020	187
14	A study of generative large language model for medical research and healthcare npj Digital Medicine ·Peng Cheng, Xi Yang, Aokun Chen, Kaleb Smith, Nima PourNejatian, Anthony Costa, Cheryl Martin, Mona G. Flores, Ying Zhang, Tanja Magoč, Gloria Lipori, Duane A. Mitchell, Naykky Singh Ospina, Mustafa M. Ahmed, William R. Hogan, Elizabeth Shenkman, Yi Guo, Jiang Bian, Yonghui Wu	2023	186
15	Vaccine Therapies for Cancer: Then and Now Targeted Oncology ·Michael A. Morse, William R. Gwin, Duane A. Mitchell	2021	163
16	Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma Cancer Immunology Immunotherapy ·Elias Sayour, Pat McLendon, Roger E. McLendon, Gabriel De Leon, Renée M. Reynolds, Jesse Kresak, John H. Sampson, Duane A. Mitchell	2015	159
17	The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma Journal of neurosurgery ·Maryam Rahman, Joseph M. Abbatematteo, Edward K. De Leo, Paul Kubilis, Sasha Vaziri, Frank J. Bova, Elias Sayour, Duane A. Mitchell, Alfredo Quiñones‐Hinojosa	2016	146
18	Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells Clinical Cancer Research ·Peter E. Fecci, Alison E. Sweeney, Peter M. Grossi, Smita K. Nair, Christopher A. Learn, Duane A. Mitchell, Xiuyu Cui, Thomas J. Cummings, Darell D. Bigner, Eli Gilboa, John H. Sampson	2006	132
19	Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma Seminars in Immunology ·John H. Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, Darell D. Bigner	2008	128
20	Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma Proceedings of the National Academy of Sciences ·Bryan D. Choi, Chien‐Tsun Kuan, Mingqing Cai, Gary E. Archer, Duane A. Mitchell, Patrick C. Gedeon, Luis Sánchez-Pérez, Ira Pastan, Darell D. Bigner, John H. Sampson	2012	111

About Duane A. Mitchell

Duane A. Mitchell is a scholar working on Immunology, Genetics, Oncology, Biotechnology and Molecular Biology, having authored 181 papers that have together received 9.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (95 papers), CAR-T cell therapy research (57 papers), Cancer Immunotherapy and Biomarkers (50 papers), Glioma Diagnosis and Treatment (46 papers), RNA Interference and Gene Delivery (35 papers), Immune Cell Function and Interaction (22 papers), Immune cells in cancer (16 papers) and Cancer Research and Treatments (12 papers). The work is most often cited by research in Genetics (2.8k citations), Immunology (4.7k citations), Health Informatics (262 citations), Oncology (4.0k citations) and Cancer Research (923 citations). Duane A. Mitchell has collaborated with scholars based in United States, China and Germany. Frequent co-authors include John H. Sampson, Darell D. Bigner, Gary E. Archer, Elias Sayour, James E. Herndon, Smita K. Nair, Allan H. Friedman, Roger E. McLendon, David A. Reardon and Amy B. Heimberger. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Clinical Cancer Research, OncoImmunology and Journal of Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact